Detalhe da pesquisa
1.
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Blood
; 141(7): 756-765, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36327160
2.
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Blood
; 136(1): 144-147, 2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462179
3.
Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19.
Ann Hematol
; 100(3): 833-835, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740681
4.
Plasma hemoglobin in COVID-19: authors' reply.
Ann Hematol
; 100(8): 2127, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159238
5.
Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
Br J Haematol
; 190(2): e73-e76, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433778
6.
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
Blood Adv
; 8(1): 236-247, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772981
7.
Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma.
Blood Adv
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776397
8.
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support.
Bone Marrow Transplant
; 58(1): 80-86, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261708
9.
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.
Blood Cancer Discov
; 4(6): 440-451, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769148
10.
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Blood Adv
; 7(6): 1056-1064, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018226
11.
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.
Clin Lymphoma Myeloma Leuk
; 22(5): 297-304, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844892
12.
Anti-body building: The exercise of advancing immune based myeloma therapies.
Blood Rev
; 48: 100789, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33384171
13.
Therapeutic potential of isatuximab in the treatment of multiple myeloma: Evidence to date.
Semin Oncol
; 47(2-3): 155-164, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446599
14.
Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis.
Int J Lab Hematol
; 42(6): 773-779, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32790918
15.
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Thromb Res
; 196: 99-105, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853982
16.
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma.
Hepatol Int
; 13(5): 609-617, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31372942
17.
HIV portends a poor prognosis in myelodysplastic syndromes.
Leuk Lymphoma
; 60(14): 3529-3535, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31282240